LOW INCIDENCE OF BCR-ABL TRANSCRIPTS IN ESSENTIAL THROMBOCYTHEMIA
Panovska I, Pavkovic M, Cevreska L, Efremov DG*
*Corresponding Author: Dimitar G. Efremov, M.D., Ph.D., Associate Professor of Medicine, Department of Hematology, Faculty of Medicine, Vodnjanska 17, 1000 Skopje, Republic of Macedonia; Tel: +389-2-147775; Fax: +389-2-110548; E-mail: defremov@mt.net.mk
page: 17

MATERIALS AND METHODS

We investigated 56 consecutive patients with ET (24 males and 32 females; median age 47 years; age range 33 to 69) who presented at our Department during the last 4 years. Routine laboratory investigations, peripheral blood smears, leukocyte alkaline phosphatase (LAP) score and bone marrow examination were carried out in all cases. All patients fulfilled the criteria for diagnosis of ET de­fined by the PVSG [3].


The detection of the two subtypes of BCR-ABL tran­scripts, b2/a2 and b3/a2, was performed by reverse transcriptase-polymerase chain reaction (RT-PCR) on total RNA extracted from bone marrow and peripheral blood samples. Total cellular RNA was extracted by the method of Chomczynski and Sacchi [15]. Complementary DNA (cDNA) was synthesized using random hexamers and the GeneAmp RNA/PCR kit (Perkin Elmer Cetus, Norwalk, CT, USA), following the recommendations of the manufacturer. The following primers were used: con­sensus ABL 3 (5’-CCG CTG CTC AGC AGA TAC TC-3’), BCR 1 (5’-TGC AGA GTG GAG GGA GAA CAT-3’) and ABL 4 (5’-CTT CTC GCT GGA CCC AGT GA-3’). PCR was performed in a DNA Thermal cycler 2400 (Perkin Elmer Cetus) under the following conditions: 1 min. at 95°C, 1 min. at 65°C, 90 seconds at 72°C, for a total of 45 cycles. The PCR products were visualized after electrophoresis on 2% agarose gels with ethidium bromide and UV illumination. The size of the obtained fragments was 496 and 571 bp, respectively, for the b2/a2 and b3/a2 transcript, and 260 bp for the control ABL product.




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006